1.00 / AMA PRA Category 1 CreditTM 1.00 / CNE Contact Hour (1.00 of which is eligible for pharmacology credit) 1.00 / AAP Credit
Provided by Boston University School of Medicine
This educational activity is supported by an educational grant from GlaxoSmithKline.
Given how disabling diseases can be that could have been prevented with vaccination, it is essential that healthcare workers delivering vaccinations enhance their standards of care in practice in order to deliver the highest rates of preventative care. Learn how you can initiate practice changes so as to improve immunization rates for your patients who are currently scheduled for the MnB vaccination. We will also touch on information specific to maternal health and retail clinic vaccination.
Pediatricians, primary care physicians, OB-GYNs, infectious disease specialists, nurse practitioners (NPs), physician assistants (PAs), nurses and other clinicians who care for patients who are scheduled to receive the Meningococcal B vaccine, as well as those clinicians who routinely care for expectant mothers
Upon completion of these activities, participants should be better able to:
Discuss the epidemiology of MnB in the United States and the profiles of patients at greatest risk for this vaccine-preventable disease
Describe recent 2015 MnB immunization updates made by the Advisory Committee on Immunization Practices (ACIP) and the rationale behind a category B recommendation
Examine the mechanism of action, contraindications, and adverse effect profiles of current MnB vaccines
Recognize and respond to the opportunity to counsel and screen expectant mothers for recommended immunizations
Conflict Of Interest Disclosure Policy
Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to activity participants prior to the start of the educational activity.
Stephen I. Pelton, MD - Course Director Professor of Pediatrics Boston University School of Medicine Professor of Epidemiology Boston University School of Public Health Director, Section of Pediatric Infectious Diseases Boston Medical Center, Boston, MA
Dr. Pelton receives Grant/ Research/Clinical Trial Support from Pfizer; Merck and Cempra. He is a Consultant for Pfizer, GSK, Sanofi and Sequiris.
Carole Moloney, RN, MSN, CPNP Clinical Instructor of Pediatrics Boston University School of Medicine Pediatric Infectious Diseases Boston Medical Center, Boston, MA
Carol Moloney, RN MSN CPNP is a consultant for Sanofi.
Amanda Smith, MD – Course Co-Director Internal Medicine/Pediatrics University of Louisville School of Medicine, Louisville, KY
Dr. Smith has no relevant relationships to disclose.
Patti Ann Collins, DNP MSN/MBA, RN CNE Course Advisor Boston University School of Medicine CME/CNE Boston, MA
Patti Ann Collins, DNP MSN/MBA, RN, Lead Nurse Planner and CNE Course Advisor has no relevant relationships to disclose.
Accredited Provider Disclosure
Planning Committee: Sheldon Kaplan, MD, faculty, receives grant/research/ clinical trial support from Pfizer, Cubist, and Forest Lab.
Gary S. Marshall, MD is on the advisory board and an investigator for GSK, Merck, Novartis, Pfizer and Seqirus. He is a speaker for Pfizer and Sanofi.
Elizabeth Drury, Dana Frazier, and Julie White, planning committee members, have no relevant relationships to disclose.
Lee Wetzler, MD, content contributor, is an advisor for GSK.
AMA PRA Category 1 Credit(s)TM
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Boston University School of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This continuing medical education activity has been reviewed by the American Academy of Pediatrics and is acceptable for a maximum of 1.00 AAP credits. These credits can be applied toward the AAP CME/CPD Award available to Fellows and Candidate Members of the American Academy of Pediatrics.
CNE Contact Hour(s)
Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Contact Hours: 1.00 all of which are eligible for pharmacology credit.
Contact Hours: 1.00 (1.00 of which is designated for pharmacology credit)
Disclosure of Unlabeled Use
This activity does not include discussion of off-label use.
THIS CONTINUING MEDICAL EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED.
To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/Exam History, which you can access at any time.